These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2021793)

  • 1. In vivo phosphorus-31 magnetic resonance spectroscopy of normal and pathological breast tissues.
    Redmond OM; Stack JP; O'Connor NG; Codd MB; Ennis JT
    Br J Radiol; 1991 Mar; 64(759):210-6. PubMed ID: 2021793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorus-31 metabolism of human breast--an in vivo magnetic resonance spectroscopic study at 1.5 Tesla.
    Twelves CJ; Lowry M; Porter DA; Dobbs NA; Graves PE; Smith MA; Richards MA
    Br J Radiol; 1994 Jan; 67(793):36-45. PubMed ID: 8298873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.
    Sijens PE; Wijrdeman HK; Moerland MA; Bakker CJ; Vermeulen JW; Luyten PR
    Radiology; 1988 Dec; 169(3):615-20. PubMed ID: 2847230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical magnetic resonance spectroscopy of human breast disease.
    Merchant TE; Thelissen GR; de Graaf PW; Den Otter W; Glonek T
    Invest Radiol; 1991 Dec; 26(12):1053-9. PubMed ID: 1765437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast tumors: evaluation with P-31 MR spectroscopy.
    Degani H; Horowitz A; Itzchak Y
    Radiology; 1986 Oct; 161(1):53-5. PubMed ID: 3020609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.
    Twelves CJ; Porter DA; Lowry M; Dobbs NA; Graves PE; Smith MA; Rubens RD; Richards MA
    Br J Cancer; 1994 Jun; 69(6):1151-6. PubMed ID: 8198985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
    Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
    J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of the breast. Work in progress.
    El Yousef SJ; Duchesneau RH; Alfidi RJ; Haaga JR; Bryan PJ; LiPuma JP
    Radiology; 1984 Mar; 150(3):761-6. PubMed ID: 6695077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate metabolites and steroid hormone receptors of benign and malignant breast tumors. A Nuclear Magnetic Resonance study.
    Barzilai A; Horowitz A; Geier A; Degani H
    Cancer; 1991 Jun; 67(11):2919-25. PubMed ID: 1851051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in the diagnosis of breast disease.
    Dash N; Lupetin AR; Daffner RH; Deeb ZL; Sefczek RJ; Schapiro RL
    AJR Am J Roentgenol; 1986 Jan; 146(1):119-25. PubMed ID: 3484399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
    Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
    J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of the human breast: a Phase I trial.
    El Yousef SJ; Duchesneau RH
    Radiol Clin North Am; 1984 Dec; 22(4):859-68. PubMed ID: 6096921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prototype coil for magnetic resonance imaging of the female breast. Work in progress.
    Stelling CB; Wang PC; Lieber A; Mattingly SS; Griffen WO; Powell DE
    Radiology; 1985 Feb; 154(2):457-62. PubMed ID: 3966132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
    Mackinnon WB; Barry PA; Malycha PL; Gillett DJ; Russell P; Lean CL; Doran ST; Barraclough BH; Bilous M; Mountford CE
    Radiology; 1997 Sep; 204(3):661-6. PubMed ID: 9280241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
    Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
    Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.
    Thakur SB; Brennan SB; Ishill NM; Morris EA; Liberman L; Dershaw DD; Bartella L; Koutcher JA; Huang W
    J Magn Reson Imaging; 2011 Apr; 33(4):855-63. PubMed ID: 21448950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy.
    Negendank WG; Crowley MG; Ryan JR; Keller NA; Evelhoch JL
    Radiology; 1989 Oct; 173(1):181-8. PubMed ID: 2675183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.